Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-31

Clinical Trial Update: Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating bismuth quadruple therapy for Helicobacter pylori infection using different tetracycline doses and dosing frequencies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bismuth quadruple therapy

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN